TAGAP restrains myeloid and T cell activation in inflammatory bowel disease

These findings demonstrated the role of TAGAP in immune responses and homeostasis. The E147K variant underscores TAGAP's protective function in IBD, and further investigation is warranted to translate these insights into therapeutic strategies for autoimmune diseases.

Authors

RuiCi Lin (ORCID: https://orcid.org/0000-0002-8748-2676)
Zhifei Shao

Institutions

Inflammation Research Foundation (US)

Publication Details

Journal: Frontiers in Immunology
Published: 2025-09-22
DOI: https://doi.org/10.3389/fimmu.2025.1641365
Primary Topic: Inflammatory Bowel Disease
Type: article
Field-Weighted Citation Impact: 0.00

Funders

Amgen

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

TAGAP restrains myeloid and T cell activation in inflammatory bowel disease

RuiCi Lin, Zhifei Shao

Sep 22, 2025

Frontiers in Immunology

Inflammatory Bowel Disease

article

TAGAP restrains myeloid and T cell activation in inflammatory bowel disease

RuiCi Lin, Zhifei Shao

September 22, 2025article en

Abstract

Frontiers in ImmunologyVol. 16

Inflammation Research Foundation (US)

Amgen

Openalex Percentile: Top 72%

Inflammatory Bowel Disease

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

TAGAP restrains myeloid and T cell activation in inflammatory bowel disease — RuiCi Lin, Zhifei Shao · Frontiers in Immunology (2025) | TGRS Research Map | TGRS